{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T04:26:47Z","timestamp":1783744007795,"version":"3.55.0"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,17]],"date-time":"2023-06-17T00:00:00Z","timestamp":1686960000000},"content-version":"am","delay-in-days":320,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["R01-CA124633"],"award-info":[{"award-number":["R01-CA124633"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Pathology"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.humpath.2022.05.015","type":"journal-article","created":{"date-parts":[[2022,5,24]],"date-time":"2022-05-24T11:18:19Z","timestamp":1653391099000},"page":"87-99","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["NUT carcinoma, an under-recognized malignancy: a clinicopathologic and molecular series of 6 cases showing a subset of patients with better prognosis and a rare ZNF532::NUTM1 fusion"],"prefix":"10.1016","volume":"126","author":[{"given":"Rodrigo Fonseca","family":"Abreu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thiago Bueno de","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans","family":"Hertzler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronaldo Nunes","family":"Toledo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felipe","family":"D'Almeida Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cl\u00f3vis Antonio","family":"Lopes Pinto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Warley Abreu","family":"Nunes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra F.","family":"Nascimento","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher Alexander","family":"French","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio Geraldo","family":"Nascimento","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.humpath.2022.05.015_bib1","doi-asserted-by":"crossref","first-page":"4135","DOI":"10.1200\/JCO.2004.02.107","article-title":"Midline carcinoma of children and young adults with NUT rearrangement","volume":"22","author":"French","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.humpath.2022.05.015_bib2","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1097\/PAS.0b013e318198d666","article-title":"Diagnosis of NUT midline carcinoma using a NUT-specific monoclonal antibody","volume":"33","author":"Haack","year":"2009","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2022.05.015_bib3","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1097\/PAS.0000000000001693","article-title":"NUT is a specific immunohistochemical marker for the diagnosis of YAP1-NUTM1-rearranged cutaneous poroid neoplasms","volume":"45","author":"Macagno","year":"2021","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2022.05.015_bib4","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s00428-019-02623-8","article-title":"Sarcoma with MGA-NUTM1 fusion in the lung: an emerging entity","volume":"476","author":"Goto","year":"2020","journal-title":"Virchows Arch"},{"key":"10.1016\/j.humpath.2022.05.015_bib5","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1038\/s41379-021-00792-z","article-title":"NUTM1-rearranged colorectal sarcoma: a clinicopathologically and genetically distinctive malignant neoplasm with a poor prognosis","volume":"34","author":"Van Treeck","year":"2021","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2022.05.015_bib6","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/nrc3659","article-title":"NUT midline carcinoma","volume":"14","author":"French","year":"2014","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.humpath.2022.05.015_bib7","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1002\/cncy.21761","article-title":"Cytopathologic features of NUT midline carcinoma: a series of 26 specimens from 13 patients","volume":"124","author":"Bishop","year":"2016","journal-title":"Cancer Cytopathol"},{"key":"10.1016\/j.humpath.2022.05.015_bib8","doi-asserted-by":"crossref","first-page":"pkz094","DOI":"10.1093\/jncics\/pkz094","article-title":"An anatomical site and genetic-based prognostic model for patients with nuclear protein in testis (NUT) midline carcinoma: analysis of 124 patients","volume":"4","author":"Chau","year":"2019","journal-title":"JNCI Cancer Spectr"},{"key":"10.1016\/j.humpath.2022.05.015_bib9","doi-asserted-by":"crossref","first-page":"5773","DOI":"10.1158\/1078-0432.CCR-12-1153","article-title":"Clinicopathologic features and long-term outcomes of NUT midline carcinoma","volume":"18","author":"Bauer","year":"2012","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.humpath.2022.05.015_bib10","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1111\/pin.12727","article-title":"NUT Carcinoma: clinicopathologic features, pathogenesis, and treatment","volume":"68","author":"French","year":"2018","journal-title":"Pathol Int"},{"key":"10.1016\/j.humpath.2022.05.015_bib11","doi-asserted-by":"crossref","first-page":"S55","DOI":"10.1007\/s12105-012-0363-6","article-title":"HPV-related squamous cell carcinoma variants in the head and neck","volume":"6","author":"El-Mofty","year":"2012","journal-title":"Head Neck Pathol"},{"key":"10.1016\/j.humpath.2022.05.015_bib12","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/S0968-6053(03)00069-3","article-title":"MINI-SYMPOSIUM: HEAD AND NECK PATHOLOGY Squamous cell carcinoma variants of the head and neck","volume":"9","author":"Thompson","year":"2003","journal-title":"Curr Diagn Pathol"},{"key":"10.1016\/j.humpath.2022.05.015_bib13","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1097\/PAS.0b013e31824230a8","article-title":"NUT midline carcinoma: report of 2 cases suggestive of pulmonary origin","volume":"36","author":"Tanaka","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2022.05.015_bib14","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.prp.2014.07.006","article-title":"NUT midline carcinoma of the mediastinum showing two types of poorly differentiated tumor cells: a case report and a literature review","volume":"211","author":"Nakamura","year":"2015","journal-title":"Pathol Res Pract"},{"key":"10.1016\/j.humpath.2022.05.015_bib15","doi-asserted-by":"crossref","first-page":"18238","DOI":"10.1073\/pnas.0607057103","article-title":"Human cancers express a mutator phenotype","volume":"103","author":"Bielas","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.humpath.2022.05.015_bib16","first-page":"304","article-title":"BRD4-NUT fusion oncogene: a novel mechanism in aggressive carcinoma","volume":"63","author":"French","year":"2003","journal-title":"Cancer Res"},{"key":"10.1016\/j.humpath.2022.05.015_bib17","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1038\/sj.onc.1210852","article-title":"BRD-NUT oncoproteins: a family of closely related nuclear proteins that block epithelial differentiation and maintain the growth of carcinoma cells","volume":"27","author":"French","year":"2008","journal-title":"Oncogene"},{"key":"10.1016\/j.humpath.2022.05.015_bib18","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1158\/2159-8290.CD-14-0014","article-title":"NSD3-NUT fusion oncoprotein in NUT midline carcinoma: implications for a novel oncogenic mechanism","volume":"4","author":"French","year":"2014","journal-title":"Cancer Discov"},{"key":"10.1016\/j.humpath.2022.05.015_bib19","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1158\/1541-7786.MCR-18-0474","article-title":"Z4\" complex member fusions in NUT carcinoma: implications for a novel oncogenic mechanism","volume":"16","author":"Shiota","year":"2018","journal-title":"Mol Cancer Res"},{"key":"10.1016\/j.humpath.2022.05.015_bib20","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1093\/annonc\/mdw686","article-title":"Complex chromosomal rearrangements by single catastrophic pathogenesis in NUT midline carcinoma","volume":"28","author":"Lee","year":"2017","journal-title":"Ann Oncol"},{"key":"10.1016\/j.humpath.2022.05.015_bib21","doi-asserted-by":"crossref","first-page":"3332","DOI":"10.1158\/0008-5472.CAN-13-2658","article-title":"Activation of SOX2 expression by BRD4-NUT oncogenic fusion drives neoplastic transformation in NUT midline carcinoma","volume":"74","author":"Wang","year":"2014","journal-title":"Cancer Res"},{"key":"10.1016\/j.humpath.2022.05.015_bib22","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1101\/gad.267583.115","article-title":"The oncogenic BRD4-NUT chromatin regulator drives aberrant transcription with in large topological domains","volume":"29","author":"Alekseyenko","year":"2015","journal-title":"Genes Dev"},{"key":"10.1016\/j.humpath.2022.05.015_bib23","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1038\/onc.2013.126","article-title":"MYC, a downstream target of BRD-NUT, is necessary and sufficient for the blockade of differentiation in NUT midline carcinoma","volume":"33","author":"Grayson","year":"2014","journal-title":"Oncogene"},{"key":"10.1016\/j.humpath.2022.05.015_bib24","doi-asserted-by":"crossref","first-page":"2943","DOI":"10.1038\/emboj.2010.176","article-title":"Oncogenesis by sequestration of CBP\/p300 in transcriptionally in active hyperacetylated chromatin domains","volume":"29","author":"Reynoird","year":"2010","journal-title":"EMBO J"},{"key":"10.1016\/j.humpath.2022.05.015_bib25","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1038\/nature09504","article-title":"Selective inhibition of BET bromodomains","volume":"468","author":"Filippakopoulos","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.humpath.2022.05.015_bib26","doi-asserted-by":"crossref","first-page":"E4184","DOI":"10.1073\/pnas.1702086114","article-title":"Ectopic protein interactions within BRD4-chromatin complexes drive oncogenic mega domain formation in NUT midline carcinoma","volume":"114","author":"Alekseyenko","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.humpath.2022.05.015_bib27","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1002\/gcc.22785","article-title":"Primary malignant epithelioid and rhabdoid tumor of bone harboring ZNF532-NUTM1 fusion: the expanding NUT cancer family","volume":"58","author":"Chien","year":"2019","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.humpath.2022.05.015_bib28","first-page":"281","article-title":"Misleading germ cell phenotype in pulmonary NUT\u00a0carcinoma harboring the ZNF532-NUTM1 fusion","volume":"46","author":"Agaimy","year":"2022","journal-title":"Am J Surg\u00a0Pathol"},{"key":"10.1016\/j.humpath.2022.05.015_bib29","doi-asserted-by":"crossref","DOI":"10.1007\/s00428-021-03253-9","article-title":"NUT carcinoma of the parotid gland: report of two cases, one with a rare ZNF532-NUTM1 fusion","author":"Chen","year":"2022","journal-title":"Virchows Arch"},{"key":"10.1016\/j.humpath.2022.05.015_bib30","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s11684-020-0821-6","article-title":"Emerging molecular subtypes and therapeutic targets in B-cell precursor acute lymphoblastic leukemia","volume":"15","author":"Li","year":"2021","journal-title":"Front Med"},{"key":"10.1016\/j.humpath.2022.05.015_bib31","doi-asserted-by":"crossref","first-page":"3632","DOI":"10.1002\/cncr.30242","article-title":"Intensive treatment and survival outcomes in NUT midline carcinoma of the head and neck","volume":"122","author":"Chau","year":"2016","journal-title":"Cancer"},{"key":"10.1016\/j.humpath.2022.05.015_bib32","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1038\/s41416-020-01180-1","article-title":"A Phase 1 study of RO6870810, a novel bromodomain and extra-terminal protein inhibitor, in patients with NUT carcinoma, other solid tumours, or diffuse large B-cell lymphoma","volume":"124","author":"Shapiro","year":"2021","journal-title":"Br J Cancer"},{"key":"10.1016\/j.humpath.2022.05.015_bib33","doi-asserted-by":"crossref","first-page":"2686","DOI":"10.1158\/0008-5472.CAN-10-3513","article-title":"Differentiation of NUT midline carcinoma by epigenomic reprogramming","volume":"71","author":"Schwartz","year":"2011","journal-title":"Cancer Res"},{"key":"10.1016\/j.humpath.2022.05.015_bib34","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1158\/1541-7786.MCR-21-0259","article-title":"Chemical screen identifies diverse and novel histone deacetylase inhibitors as repressors of NUT function: implications for NUT carcinoma pathogenesis and treatment","volume":"19","author":"Shiota","year":"2021","journal-title":"Mol Cancer Res"}],"container-title":["Human Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817722001423?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817722001423?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T16:40:19Z","timestamp":1758645619000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0046817722001423"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":34,"alternative-id":["S0046817722001423"],"URL":"https:\/\/doi.org\/10.1016\/j.humpath.2022.05.015","relation":{},"ISSN":["0046-8177"],"issn-type":[{"value":"0046-8177","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"NUT carcinoma, an under-recognized malignancy: a clinicopathologic and molecular series of 6 cases showing a subset of patients with better prognosis and a rare ZNF532::NUTM1 fusion","name":"articletitle","label":"Article Title"},{"value":"Human Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humpath.2022.05.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}